Brazilian Journal of Otorhinolaryngology (English Edition) Brazilian Journal of Otorhinolaryngology (English Edition)
Original article
Multidimensional effects of voice therapy in patients affected by unilateral vocal fold paralysis due to cancer
Efeitos multidimensionais da terapia vocal em pacientes com paralisia unilateral da prega vocal por câncer
Camila Barbosa Barcelosa, Paula Angélica Lorenzon Silveirab, Renata Lígia Vieira Guedesa,, , Aline Nogueira Gonçalvesa, Luciana Dall’Agnol Siqueira Slobodticova, Elisabete Carrara-de Angelisa
a AC Camargo Cancer Center, Fonoaudiologia, São Paulo, SP, Brazil
b AC Camargo Cancer Center, Departamento de Otorrinolaringologia e Cirurgia de Cabeça e Pescoço, São Paulo, SP, Brazil
Received 05 May 2017, Accepted 28 July 2017

Patients with unilateral vocal fold paralysis may demonstrate different degrees of voice perturbation depending on the position of the paralyzed vocal fold. Understanding the effectiveness of voice therapy in this population may be an important coefficient to define the therapeutic approach.


To evaluate the voice therapy effectiveness in the short, medium and long-term in patients with unilateral vocal fold paralysis and determine the risk factors for voice rehabilitation failure.


Prospective study with 61 patients affected by unilateral vocal fold paralysis enrolled. Each subject had voice therapy with an experienced speech pathologist twice a week. A multidimensional assessment protocol was used pre-treatment and in three different times after voice treatment initiation: short-term (1–3 months), medium-term (4–6 months) and long-term (12 months); it included videoendoscopy, maximum phonation time, GRBASI scale, acoustic voice analysis and the portuguese version of the voice handicap index.


Multiple comparisons for GRBASI scale and VHI revealed statistically significant differences, except between medium and long term (p<0.005). The data suggest that there is vocal improvement over time with stabilization results after 6 months (medium term). From the 28 patients with permanent unilateral vocal fold paralysis, 18 (69.2%) reached complete glottal closure following vocal therapy (p=0.001). The logistic regression method indicated that the Jitter entered the final model as a risk factor for partial improvement. For every unit of increased jitter, there was an increase of 0.1% (1.001) of the chance for partial improvement, which means an increase on no full improvement chance during rehabilitation.


Vocal rehabilitation improves perceptual and acoustic voice parameters and voice handicap index, besides favor glottal closure in patients with unilateral vocal fold paralysis. The results were also permanent during the period of 1 year. The Jitter value, when elevated, is a risk factor for the voice therapy success.


Pacientes com paralisia unilateral de prega vocal podem demonstrar diferentes graus de distúrbios da voz, dependendo da posição da prega vocal paralisada. A compreensão da eficácia da terapia vocal nesta população pode ser um coeficiente importante para definir a abordagem terapêutica.


Avaliar a eficácia da terapia vocal em curto, médio e longo prazos em pacientes com paralisia unilateral de prega vocal e determinar os fatores de risco para falha na reabilitação da voz.


Estudo prospectivo, no qual 61 pacientes com paralisia uilateral de prega vocal foram recrutados. Cada indivíduo foi submetido a terapia vocal com um fonoaudiólogo experiente duas vezes por semana. Um protocolo de avaliação multidimensional foi utilizado no pré-tratamento e em três momentos diferentes após o início da terapia da voz: curto prazo (1-3 meses), médio prazo (4-6 meses) e longo prazo (12 meses); incluiu vídeo-endoscopia, tempo máximo de fonação, escala GRBASI, análise de voz acústica e a versão em português do Voice Handicap Index.


Os dados comparativos temporais das avaliações revelaram diferenças estatisticamente significativas, exceto entre médio e longo prazo (p<0,005). Os dados sugerem que há melhora vocal ao longo do tempo com resultados de estabilização após 6 meses (médio prazo). Dos 28 pacientes com paralisia unilateral permanente da prega vocal, 18 (69,2%) atingiram o fechamento glótico completo após a terapia vocal (p=0,001). O método de regressão logística indicou que o Jitter entrou no modelo final como um fator de risco para melhora parcial. Para cada unidade de aumento de jitter, houve um aumento de 0,1% (1,001) da chance de melhora parcial, o que significa um aumento na chance de não ocorrer melhora completa durante a reabilitação.


A reabilitação vocal melhora os parâmetros de voz perceptiva e acústica e o índice de incapacidade vocal, além de favorecer o fechamento glótico em pacientes com paralisia unilateral da prega vocal. Além disso, os resultados também foram permanentes durante o período de 1 ano. O valor de Jitter, quando elevado, é um fator de risco para sucesso parcial da terapia vocal.

Voice disorders, Vocal fold paralysis, Voice Therapy, Therapy
Paralisia das pregas vocais, Voz, Distúrbios vocais, Reabilitação
This article is only available in PDF

Unilateral vocal fold paralysis (UVFP) may present as dysphonia, loss of the upper register of the voice, hoarseness, breathiness, throat pain, choking episodes or decreased vocal stamina.1–5 Patients with UVFP may demonstrate different degrees of voice perturbation depending on the position of the paralyzed vocal fold.6–8

Treatment of unilateral vocal fold paralysis is designed to eliminate aspiration and improve quality of the voice. Different surgical techniques are available today: teflon, collagen, hydroxiapatite or autogenous micronized dermis, fat injection, type I thyroplasty and nerve muscle pedicle transfer represent the surgical techniques mainly adopted. These studies conduct evaluations mostly in the immediate post-surgery period and three months after surgery.9–18

Only three studies have evaluated voice therapy efficacy for this population. Schindler et al.19 analyzed retrospectively voice modifications in 40 patients with UVFP from different etiologies before and after voice therapy. A multidimensional assessment protocol was used and it included videoendoscopy, the maximum phonation time (MPT), the GRBASI scale, spectrograms, perturbation analysis and the voice handicap index (VHI). Pre and post early treatment data were compared. A complete glottal closure was seen in 8 patients before voice therapy and in 14 afterwards. Mean MPT increased significantly. In the perceptual assessment, the difference was significant for five out of six parameters and a significant improvement on quality of life was also reached. D’Alatri et al.20 evaluated the laryngological and acoustical results obtained after voice therapy in 8 patients with UVFP caused by different etiologies. After behavioral therapy, the prevalence of complete glottal closure increased significantly (p<0.05). Subjects’ pre-therapy mean values for Jitter, Shimmer and noise-to-harmonic ratio were significantly different from those taken both immediately and 6 months after treatment (p<0.05). Mattioli et al.21 conducted a 7 years prospective study to evaluate the post vocal early treatment results of 74 patients with UVFP. Patients underwent multidimensional assessment pre and post treatment and the results shown that 51 (68.9%) patients recovered vocal fold mobility, and 23 (31.1%) had persistent paralysis after voice therapy. In this group of patients, complete glottal closure was observed in 5 cases before the voice therapy, and in 13 patients this complete closure was observed only after the therapeutic process (p<0.0001). An important and significant reduction in fundamental frequency was found (p<0.0001); an improvement was seen for the mean values of Jitter (Jitt%; p=0.001), Shimmer (Shim%; p<0.0001) and noise-to-harmonic ratio (NHR) (p<0.0001). Voice handicap index (VHI) values showed a clear and significant improvement and mean MPT increased significantly.

At this time, there are no studies that report the risk factors for vocal improvement after voice therapy. Although there are three previous studies demonstrating the efficacy of voice therapy for patients with UVFP, there are no multidimensional studies that evaluate the long term.

Understanding the effectiveness of voice therapy in this population may be an important coefficient to define the therapeutic approach. Voice therapy is the noninvasive intervention and an understand of factors listed above is essential for adequate indication. This is the first study that evaluated the voice therapy effectiveness for short, medium and long term in oncological patients with UVFP and that determine the risk factors for voice rehabilitation failure.


This study was approved by the Institution Ethics Committee (n° 1399/10). A total of 61 patients affected by UVFP were enrolled in a prospective study. Inclusion criteria included adults with UVFP diagnosis without structural lesions or previous dysphonia. The study group comprised 16 (26.2%) men and 45 (73.8%) women, with a mean age of 52.4 (SD=13.8) years. The UVFP etiology was due to different types of cancer treatment, including thyroid (44.69%), lung (11.5%), esophagus (5.0%) and seven other different locations (14%).

From the 61 patients included, 43 finished the voice rehabilitation treatment. Nine of them declined, and nine patients had worsening their clinical oncologic condition. After voice therapy, UVFP persisted in 28/43 (65.2%) patients. For multidimensional analysis only the 28 patients who remained with UVFP were recorded.

Concerning clinical analysis, the patients were divided in three groups: “overall improvement” – individuals who had all vocal and acoustic appropriate parameters, improvement in quality of life and no complaints; “partial improvement” – individuals without complaints, however with persistence of discrete changes in individual parameters; “failure” – individuals who did not present vocal, as well as acoustic parameters and/or life quality improvement.

Multidimensional assessment

Patients were assessed pretreatment and at 3 different times after voice treatment: short term (1–3 months), medium term (4–6 months) and long term (12 months).


Each subject underwent videolaryngoscopy evaluation with a flexible endoscope. Endoscopic examinations were conducted using a Kay9105 endoscope coupled with a Panasonic GP micro camera (model AD22TA) connected to a Sony14 inch monitor and a Philips DVD-R 335HDD. The larynx was evaluated during breathing and sustained phonation of vowels /e/ and /i/ in randomized order for the assessment time point (pre, short, medium or long term). The examiner was blinded to the timing of the evaluation. On the basis of videolaryngoscopic images, each patient was evaluated according to mobility of the vocal folds and UVFP position. For the evaluation analysis, an adapted protocol was used.22,23

Perceptual voice analysis

Perceptual evaluation was based on the GRBASI scale.24–27 The vocal samples were computer recorded using the Multi-Dimensional Voice Program (MDVP) from the patient's mouth during the production of a sustained /a/. All of the vocal samples were subsequently evaluated by three experienced judges (speech language therapists) with no knowledge about when the voice was recorded (pre, short, medium or long term). Five days after the first evaluation, 35% of the voices were re-tested. Both results were evaluated using a Kappa test, and the most analogous judgment result was chosen for the study.

Maximum phonation time

This was obtained during a sustained /a/ at comfortable pitch and loudness after a profound inspiration. Three consecutive trials were performed, and the best one was considered.

Acoustic voice analysis

Acoustic voice analysis was performed with a Multi-Dimensional Voice Program (MDVP, Kay Pentax). Subjects were asked to sustain the vowel /a/ at a comfortable pitch and loudness level for at least four seconds. A three-second interval was selected, eliminating the beginning and the final emission. The following parameters were considered: mean fundamental frequency (Mean F0, hertz), Jitter%, PPQ, Shimmer%, APQ, fundamental frequency variation (vFo), amplitude variation (vAm) and Voice Turbulence Index (VTI).


Finally, each patient completed the Brazilian version of the VHI to have self-assessment data on voice related quality of life.

Voice therapy

Voice therapy was individualized, two times per week, for 30minutes. Each patient involved in the study had several voice therapy sessions with an experienced speech language therapist. The mean number of sessions was 12 (SD=6.1). The voice therapy aimed to improve glottal closure and at the same time avoid undesirable compensatory behaviors, such as anterior-posterior or lateral constriction of the vocal folds, falsetto voice and oral or pharyngeal muscle tension.

At the first session, the speech-language pathologist provided patients with educational information about the workings of phonation, their specific abnormality, and vocal hygiene.

The patients were submitted to specific voice training, directed toward avoidance of hyper functional compensation: vocal fold vibration and forced adduction exercises, such as pushing or pulling on chair. Patients who used falsetto register compensation were oriented to bring out the chest voice by moving the larynx to lower position in the neck (manually or using techniques such as deep inhalation and yawning). For patients with ventricular hyper function, we used techniques such as speaking on inhalation and nasal sounds.8,28–33

All the therapeutic processes were conducted with visual feedback of the acoustic parameters to help choose the best technique for therapy, as well as to facilitate patient results observation.

Statistical analysis

Statistical analyses were performed using the SPSS 11.5 package (SPSS Science, Chicago, IL). For quantitative variables, the Chi-Square and Fisher's exact test (F) were used. For comparison between two groups, Student's t test was used. Analysis of variance (ANOVA) was used for other analyses. When homogeneity of variances was not verified, adjustment was performed with the Brown–Forsythe (BF) test.

To evaluate the longitudinal characteristics, the Repeated Measures for Ordinal Data test was used. When differences were identified between the evaluations, multiple comparisons were made specifically for this test.

When there was a significant difference between times, to identify differences in evaluation time points, comparisons were made between the two time points using the Bonferroni test. These comparisons are presented at the end of Table 1, indicating when the p-value <0.05 (significance level considered was 5%).

Table 1.

Comparison of clinical assessment values at the four time points.

Categories  PT  ST  MT  LT  p 
  n (%)/data  n (%)/data  n (%)/data  n (%)/data   
G  (n=28)  (n=28)  (n=14)  (n=7)   
Normal  8 (28.6)  6 (42.8)  4 (57.1)   
Changed  28 (100)  20 (71.4)  8 (57.2)  3 (42.9)  0.001 
Normal  2 (7.1)  7 (25)  6 (42.8)  5 (71.5)   
Changed  26 (92.9)  21 (75)  8 (57.2)  2 (28.5)  0.001 
Normal  3 (10.7)  11 (39.3)  10 (71.4)  5 (75.5)   
Changed  25 (89.3)  17 (60.7)  4 (28.6)  2 (28.5)  0.001 
Normal  28 (100)  28 (100)  14 (100)  7 (100)   
Changed  NA 
Normal  28 (100)  28 (100)  14 (100)  7 (100)   
Changed  NA 
Normal  9 (32.1)  16 (57.1)  11 (78.6)  4 (57.1)   
Changed  19 (67.9)  12 (42.9)  3 (21.4)  3 (42.9)  0.001 
Degree of dysphonia
Normal  8 (25.9)  6 (42.9)  4 (57.1)   
Discrete  5 (17.8)  10 (37.0)  7 (50.0)  2 (28.6)   
Moderate  12 (42.9)  9 (33.3)  1 (7.1)  1 (14.3)   
Severe  11 (39.3)  1 (3.7)  0.001 
MPT /a/
Min–max  2–15  4–17  4–15  5–14   
Median  12  11   
Mean±SD  7±3.3  11.1±3.3  10.8±3.6  7±6.2  0.001 
Normal  20 (71.4)  23(82.1)  13 (92.8)  6 (85.7)   
Changed  8 (28.6)  5 (17.9)  1 (7.2)  1 (14.3)  0.001 
Normal  9 (32.1)  17 (60.7)  12 (85.7)  6 (85.7)   
Changed  19 (67.9)  11 (39.3)  2 (14.3)  1 (14.3)  0.001 

L, overall dysphonia grade; R, roughness; B, breathiness; A, asthenia; S, strain; I, instability; min, minimum; max, maximum; SD, standard deviation; PT, pre-therapy; ST, short term; MT, medium term; LT, long term.

We performed logistic regression analysis to identify the risk factors that influenced the partial and not full improvements. The variables that presented a p<0.10 in the univariate analysis were included in the initial model.

The Stepwise forward logistic regression method was used and does not include variables analyzed jointly in the final model that were not significant. Thus, only the significant variables (p<0.05) or those with a significant trend (0.05<p<0.10) were included in the final model. All other variables were not included and in all tests, a p-value of less than 0.05 was considered significant.


From the 28 patients with permanent UVFP, 18 (69.2%) presented with complete glottal closure following voice therapy (p=0.001).

Perceptive auditory analysis comparisons pre and post therapy (short, medium and long term) revealed a significant difference between the four evaluation time points for most parameters (overall dysphonia degree, roughness, breathiness, instability, maximum phonation time, loudness and pitch) (Table 1). The multiple comparisons for the GRBASI scale revealed significant differences at the different evaluation time points, except between the medium and long term time points (p<0.005). The data suggests that there was a voice improvement over time with stabilization of the results after 6 months (medium term).

The acoustic results showed improvement presented in the different stages of evaluation (pre, short, medium and long term) (Table 2). The variables that displayed significant differences were PPQ and Shimmer, which were decreased if compared to baseline. On the acoustic analysis, there were significant differences when comparing overall improvement and partial improvement for Jitter (p=0.016) and PPQ (p=0.006) parameters (Table 3).

Table 2.

Comparison of acoustic assessment data at the four time points.

Categories  PT  ST  MT  LT  p 
  Data  Data  Data  Data   
Fo – men  (n=28)  (n=28)  (n=14)  (n=7)   
Min–max  84.7–204.7  84–177.5  84–127.2  84–127.2   
Median  115.3  127.2  96.5  94.392   
Mean±SD  127.4±43.4  128.5±30.7  104.1±18.657  100.3±18.889  0.999 
Fo – women           
Min–max  186–259.7  126.8–259.7  208.8–259.7  208.8–227.8   
Median  205.5  208.8  232.0  216.7   
Mean±SD  197.9±55.2  204.4±36.937  232.8±15.932  217.8±9.546  0.999 
Jitter (0.633±0.351)
Min–max  1.218–10.443  1.197–6.355  1.203–3.662  2.266–3.662   
Median  2.718  2.056  2.067  2.964   
Mean±SD  3.398±2.254  2.686±1.695  2.041±0.861  2.964±0.987  0.999 
PPQ (0.366±0.235)
Min–max  0.256–6.945  0.164–3.877  0.164–2.398  0.169–2.398   
Median  1.550  0.368  0.644  0.308   
Mean±SD  1.963±1.448  0.857±0.961  0.733±0.623  0.722±0.841  0.010 
vFo (1.149±1.005)
Min–max  1.213–33.574  1.039–7.920  1.039–4.594  1.262–4.594   
Median  3.155  2.656  1.713  2.256   
Mean±SD  4.613±6.121  3.352±2.491  2.168±1.116  2.592±1.576  0.147 
Shimmer (1.997±0.791)
Min–max  1.787–32.859  1.210–11.201  1.378–8.977  1.378–8.977   
Median  5.855  3.060  3.046  2.690   
Mean±SD  7.375±5.868  4.072±2.811  3.823±3.046  4.271  0.001 
APQ (1.397±0.527)
Min–max  1.382–32.859  1.080–8.228  1.070–6.168  1.367–6.168   
Median  4.148  2.394  2.352  2.331   
Mean±SD  5.332±4.814  3.125±2.030  2.769±1.753  3.299±2.284  0.151 
vAm (10.743±5.6)
Min–max  5.433–43.694  7.873–19.139  4.887–17.506  4.887–17.506   
Median  13.656  10.865  9.168  9.703   
Mean±SD  16.548±9.380  11.809±3.328  10.473±3.927  11.166±4.985  0.998 
VTI (0.046±0.012)
Min–max  0.02–0.15  0.02–0.11  0.01–0.07  0.03–0.07   
Median  0.06  0.04  0.04  0.05   
Mean±SD  0.06±0.03  0.05±0.02  0.04±0.01  0.05±0.01  0.114 

SD, standard deviation; PT, pre-therapy; ST, short term; MT, medium term; LT, long term.

Table 3.

Comparison of data between acoustic group evaluation of “overall improvement” and “partial improvement”.

Categories  Overall improvement (n=16)  Partial improvement
  n (%)/data  n (%)/data   
Fo – men (n=8)  (n=2)  (n=5)   
Min–max  94–177  92 – 204   
Median  136  115   
Mean±SD  136±58.4  132±48.8  0.857 
Fo – women (n=19)  (n=14)  (n=5)   
Min–max  186–259  139–245   
Median  201  228   
Mean±SD  192±59.8  212±41.8  0.257 
Jitter (0.633±0.351)
Min–max  1.218–5.532  1.231–10.443   
Median  2.326  4.196   
Mean±SD  2.463±1.156  5.031±2.894  0.016 
PPQ (0.366±0.235)
Min–max  1.100–3.322  1.306–6.945   
Median  1.670  3.425   
Mean±SD  1.741±0.639  3.346±1.675  0.006 
vFo (1.149±1.005)
Min–max  1.213–6.873  1.436–33.574   
Median  2.620  5.849   
Mean±SD  2.695±1.432  7.943±9.902  0.027 
Shimmer (1.997±0.791)
Min–max  1.787–15.062  2.974–32.859   
Median  5.423  6.769   
Mean±SD  6.158±3.674  9.250±8.612  0.182 
APQ (1.397±0.527)
Min–max  1.382–11.181  2.099–27.237   
Median  3.619  4.919   
Mean±SD  4.321±2.639  6.970±7.288  0.121 
vAm (10.743±5.698)
Min–max  5.433–36.578  5.620–43.694   
Median  14.407  10.684   
Mean±SD  15.739±6.815  15.459±12.296  0.363 
VTI (0.046±0.012)
Min–max  0.02–0.11  0.03–0.15   
Median  0.05  0.06   
Mean±SD  0.05±0.02  0.07±0.03  0.135 

SD, standard deviation.

Comparisons of variables related to VHI questionnaire over time also displayed significant differences for all variables. For the overall score, there was a difference pre therapy compared with other time points (values were, on average, higher than at other time points) (Table 4).

Table 4.

Comparison of central tendency and variability measures related to different aspects (functional, organic, emotional) and total score of VHI between the Pre-Treatment (PT, n=28), Short-Term (ST, n=28), Medium-Term (MT, n=14) and Long-Term evaluations (LT, n=7).

Categories  PT  ST  MT  LT  p 
  Data  Data  Data  Data   
General  (n=28)  (n=28)  (n=14)  (n=7)   
Min–max  3–97  0–79  0–29  0–29   
Median  54  18.5  12   
Mean±SD  50.9±22.4  16.9±4.0  9.2±8.7  9.9±10.2  0.001 
Min–max  0–32  0–23  0–5  0–3   
Median  12   
Mean±SD  11.8±8.3  3.6±2.7  1.4±1.7  1.4±1.1  0.001 
Min–max  0–35  0–32  0–12  0–12   
Median  20   
Mean±SD  18.7±9.1  6.1±4.9  3.6±2.9  3.6±4.5  0.001 
Min–max  2–39  0–24  0–14  0–14   
Median  23   
Mean±SD  20.9±8.3  6.1±5.2  42±3.9  5±0.001 

SD, standard deviation; PT, pre-therapy; ST, short term; MT, medium term; LT, long term.

Table 5 presents the results of the logistic regression used to determine the risk factors for non-improvement. The results indicated that Jitter entered the final model as a risk factor for partial improvement. For every unit of increased Jitter, there was an increase of 0.1% (1.001) of the patient chance for partial improvement, which indicates an increase in the no full improvement chance during rehabilitation.

Table 5.

Jitter logistic regression correlation.

Categories  Descriptive level (p-value)  Odds ratio (OR)  Lower limit  Upper limit 
Jitter  0.049  1.001  1.000  1.002 
Constant  0.034  0.05     

Some studies demonstrate the effectiveness of voice therapy rehabilitation for UVFP.19–34 The present study confirms the voice improvement for medium and long term rehabilitation.

The variables pitch, loudness and MPT also displayed improvement when comparing previous and immediately post therapy evaluation results; however, when comparing the results at the medium and long term evaluations, the differences were not significant. These data show that the results achieved during therapy were maintained over time, but without progressive improvement after 6 months, suggesting vocal quality stabilization.

Acoustic analysis results (PPQ and Shimmer) indicated improvement over time. These values were on average lower in the short, medium and long term when compared to the initial assessment.

In cases with continuing permanent vocal fold paralysis, glottal closure improvement became complete in most of the patients when compared with the initial otorhinolaryngology evaluation. The presented data is consistent with other studies that have evaluated the voice rehabilitation effectiveness. Different factors are involved in glottis closure. For example, interarytenoid musculature and cricothyroid muscle action can also help in the vocal fold medial movement and finally the inferior pharyngeal constrictor muscle, which can also help glottal closure. Based on the results found after voice therapy, we suggest that all of these settings can be favored by the techniques used during speech rehabilitation.

The consulted literature did not present data defining risk factors for unsatisfactory development in voice therapy in patients with unilateral vocal fold paralysis. The sample characteristics were similar in the groups with total and partial improvement. The auditory perceptual evaluation results, otorhinolaryngology evaluation and VHI had no significant differences.

In this study, the acoustic measures were the only factor directly related to UVFP patient improvement. The literature data suggest that voice disorder analysis, besides being an easy procedure, can indirectly and noninvasively measure laryngeal function and determine the vocal fold vibration condition.35

The Jitter and Shimmer parameters are widely used in scientific and clinical performance to predict diagnoses, as well as to document and evaluate dysphonia treatment.36–38 Different authors suggest that Jitter and Shimmer can be important predictors for changes on laryngeal physiology diagnosis.39,40 However, there is controversy regarding Jitter and Shimmer analysis because of low reliability, sensitivity and specificity when voices with high roughness, low pitch and aperiodic signal are evaluated.41

In the study sample, we found the acoustic measures: Jitter, PPQ and VFO as associated factors for UVFP patient improvement. Those with partial improvement displayed, on average, higher values than these acoustic parameters. Moreover, Jitter measurement was considered a risk factor for the lack of total improvement.

Studies indicate that there is a fundamental frequency influence on Jitter results. Higher fundamental frequency values result in greater Jitter.42,43 The fundamental frequency, Jitter and Shimmer influences are not yet fully understood, and there is a need to conduct new studies to determine the reasons for these relationships.44,45

Considering the aforementioned aspects, we believe that the rate of patients with falsetto voice may have influenced the findings in this study, as this behavior can be found in patients with impaired vocal fold mobility. Brockmann et al.46 found that vocal intensity has a strong impact on Jitter and Shimmer measures. The fundamental frequency had relatively little influence.

Ortega et al.40 conducted a study on patients undergoing thyroid surgeries to determine whether subjective and acoustics voice evaluations could complement or replace laryngoscopy. Seventy-four patients were evaluated before and after surgery and submitted to acoustic analysis, subjective evaluation with GRBASI scale and nasofibrolaryngoscopy. The results indicated that Jitter, noise and harmonic variation proportion displayed the most frequent variations between the first and second evaluations (36% and 31%, respectively). Seven days after surgery, 5 (8%) patients were diagnosed with vocal fold paralysis, with a recovery of 2 cases after one month (5%). GRBASI values, Jitter and Shimmer displayed differences between patients with and without vocal fold paralysis (p<0.05) and (p<0.02). When there was a change in three voice parameters, the vocal fold paralysis was confirmed by laryngoscopy. The authors concluded that vocal fold paralysis might be observed in patients undergoing thyroidectomy, when there is a change in the GRBASI scale, Jitter or major changes of three acoustic analysis parameters. Furthermore, laryngoscopy should be performed only when these parameters have changed.

Observation of these parameters (fundamental frequency, Jitter and Shimmer) is well established as a noninvasive and objective method to quantitatively evaluate dysphonia degree and some different aspects of vocal fold paralysis. These parameters are used to describe normal and pathological voices while providing an objective method that can evaluate treatment clinical efficacy.47,48

Changes in Jitter for UVFP patients should be evaluated more carefully because patients with major changes in this measure may have a worse voice rehabilitation prognosis.


The results obtained in this study indicate that voice rehabilitation improves auditory perceptual, acoustic voice parameters and VHI parameters, in addition to favoring glottal closure in patients with vocal fold paralysis. The results were also stable over a one-year period. The Jitter value, when elevated, is a risk factor for voice therapy success.

Conflicts of interest

The authors declare no conflicts of interest.

B.J. McNeil,R. Weichselbaum,S.G. Pauker
Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer
N Engl J Med, 305 (1981), pp. 982-987
J.A. Logemann
The role of the speech language pathologist in the management of dysphagia
Otolaryngol Clin North Am, 21 (1988), pp. 783-788
C.L. Lazarus,J.A. Logemann,P.J. Kahrilas,B.B. Mittal
Swallow recovery in an oral cancer patient following surgery, radiotherapy and hyperthermia
Head Neck, 16 (1994), pp. 259-265
M.A. Crary,A.L. Glowaski
Vocal fold mobility
Organic voice disorders assessment and treatment, pp. 301-321
M. Broniatowski,B.C. Sonies,J.S. Rubin,C.R. Bradshaw,J.R. Spiegel,R.W. Bastian
Current evaluation and treatment of patients with swallowing disorders
Otolaryngol Head Neck Surg, 120 (1999), pp. 464-473
M.S. Benninger,R.L. Crumley,C.N. Ford,W.J. Gould,D.G. Hanson,R.H. Ossoff
Evaluation and treatment of the unilateral paralyzed vocal fold
Otolaryngol Head Neck Surg, 111 (1994), pp. 497-508
R.J. Heuer,R.T. Sataloff,K. Emerich,R. Rulnick,M. Baroody,J.R. Spiegel
Unilateral recurrent laryngeal nerve paralysis: the importance of “preoperative” voice therapy
J Voice, 11 (1997), pp. 88-94
S. Miller
Voice therapy for vocal fold paralysis
Otolaryngol Clin North Am, 37 (2004), pp. 105-119
J. Nouwen,S. Hans,E. De Mones,D. Brasnu,L. Crevier-Buchman,O. Laccourreye
Thyroplasty type I without arytenoid adduction in patients with unilateral laryngeal nerve paralysis: the montgomery implant versus the Gore-Tex implant
Acta Otolaryngol, 124 (2004), pp. 732-738
S. Hertegård,L. Hallén,C. Laurent,E. Lindström,K. Olofsson,P. Testad
Cross-linked hyaluronan versus collagen for injection treatment of glottal insufficiency: 2-year follow-up
Acta Otolaryngol, 124 (2004), pp. 1208-1214
C.F. Milstein,L.M. Akst,M.D. Hicks,T.I. Abelson,M. Strome
Long-term effects of micronized Alloderm injection for unilateral vocal fold paralysis
Laryngoscope, 115 (2005), pp. 1691-1696
M. Remacle,G. Lawson
Results with collagen injection into the vocal folds for medialization
Curr Opin Otolaryngol Head Neck Surg, 15 (2007), pp. 148-152
J.Y. Min,S.D. Hong,K. Kim,Y.I. Son
Long-term results of Artecoll injection laryngoplasty for patients with unilateral vocal fold motion impairment: safety and clinical efficacy
Arch Otolaryngol Head Neck Surg, 134 (2008), pp. 490-496
M.B. Gillespie,T.S. Dozier,T.A. Day,B. Martin-Harris,S.A. Nguyen
Effectiveness of calcium hydroxylapatite paste in vocal rehabilitation
Ann Otol Rhinol Laryngol, 118 (2009), pp. 546-551
D.M. Hartl,S. Hans,L. Crevier-Buchman,J. Vaissière,D.F. Brasnu
Long-term acoustic comparison of thyroplasty versus autologous fat injection
Ann Otol Rhinol Laryngol, 118 (2009), pp. 827-832
G. Bergamini,M. Alicandri-Ciufelli,G. Molteni,D. Villari,M.P. Luppi,E. Genovese
Therapy of unilateral vocal fold paralysis with polydimethylsiloxane injection laryngoplasty: our experience
L.F. Mourão
Reabilitação fonoaudiológica das imobilidades laríngeas
A atuação fonoaudiológica no câncer de cabeça e pescoço, pp. 201-207
S. Bortoncelo,M. Behlau,P. Pontes
Imobilidade unilateral de prega vocal – configurações laríngeas na avaliação clínica de rotina
A voz do especialista, pp. 257-287
A. Schindler,A. Bottero,P. Capaccio,D. Ginocchio,F. Adorni,F. Ottaviani
Vocal improvement after voice therapy in unilateral vocal fold paralysis
L. D’Alatri,S. Galla,M. Rigante,O. Antonelli,S. Buldrini,M.R. Marchese
Role of early voice therapy in patients affected by unilateral vocal fold paralysis
J Laryngol Otol, 122 (2008), pp. 936-941
F. Mattioli,G. Bergamini,M. Alicandri-Ciufelli,G. Molteni,M.P. Luppi,F. Nizzoli
The role of early voice therapy in the incidence of motility recovery in unilateral vocal fold paralysis
Logoped Phoniatr Vocol, 36 (2011), pp. 40-47
C. Pemberton,A. Russell,J. Priestley,T. Havas,J. Hooper,P. Clark
Characteristics of normal larynges under flexible fiberscopic and stroboscopic examination: an Australian perspective
J Voice, 7 (1993), pp. 382-389
M. Hirano,D.M. Bless
Padrões vibratórios típicos nas patologias vocais e suas implicações clínicas
Exame videoestroboscópica da laringe, pp. 135-206
N. Isshiki,N. Yanagihara,M. Morimoto
Approach to the objetive diagnostic of hoarseness
Folia Phoniatr (Basel), 18 (1966), pp. 383-400
P. Dejonckere,M. Remacle,E. Freznel-Elbaz
Reliability and relevance of differentiated perceptual evaluation of pathological voice quality
Voice update, pp. 321-324
J.F. Piccirillo,C. Painter,D. Fuller,A. Haiduk,J.M. Frederickson
Assessment of two objective voice function índices
Ann Otol Rhinol Laryngol, 107 (1998), pp. 396-400
R.S. McGowan
Tongue-tip trills and vocal-tract wall compliance
J Acoust Soc Am, 91 (1992), pp. 2903-2910
M.N. Kotby,O. Shiromoto,M. Hirano
The accent method of voice therapy: effect of accentuations on F0, SPL and airflow
J Voice, 7 (1993), pp. 319-325
J.C. Stemple,L. Lee,B. D’Amico,B. Pickup
Efficacy of vocal function exercises as a method of improving voice production
J Voice, 8 (1994), pp. 271-277
N. Roy,B. Weinrich,S.D. Gray,K. Tanner,J.C. Stemple,C.M. Sapienza
Three treatments for teachers with voice disorders: a randomized clinical trial
J Speech Lang Hear Res, 46 (2003), pp. 670-688
K. Verdolini,D.G. Druker,P.M. Palmer,H. Samawi
Laryngeal adduction in resonant voice
J Voice, 12 (1998), pp. 315-327
S. McFarlane,T. Watterson,K. Lewis,D. Boone
Effect of voice therapy facilitation techniques on airflow in unilateral paralysis patients
Phonoscope, 1 (1998), pp. 187-191
G. Cantarella,S. Viglione,S. Forti,L. Pignataro
Voice therapy for laryngeal hemiplegia: the role of timing of initiation of therapy
J Rehabil Med, 42 (2010), pp. 442-446
R.J. Baken,R.F. Orlikoff
Amplitude pertubation (shimmer)
Clinical measurements of speech and voice, Thomson Delmar Learning;, (2000)pp. 127-130
F.S. Hodge,R.H. Colton,R.T. Kelley
Vocal intensity characteristics in normal and elderly speakers
E.P. Ma,E.M. Yiu
Multiparametric evaluation of dysphonic severity
J Voice, (2006), pp. 380-390
E.V. Sjögren,M.A. Van Rossum,T.P. Langeveld,M.S. Voerman,V.A. van de Kamp,M.O. Friebel
Voice outcome in T1a midcord glottis carcinoma: laser surgery vs radiotherapy
Arch Otolaryngol Head Neck Surg, 134 (2008), pp. 965-972
A. Gelzinis,A. Verikas,M. Bacauskiene
Automated speech analysis applied to laryngeal disease categorization
Comput Methods Programs Biomed, 91 (2008), pp. 36-47
J. Ortega,N. Cassinello,D. Dorcaratto,E. Leopaldi
Computerized acoustic voice analysis and subjective scaled evaluation of the voice can avoid the need for laryngoscopy after thyroid surgery
C.R. Rabinov,J. Kreiman,B.R. Gerratt,S. Bielamowicz
Comparing reliability of perceptual ratings of roughness and acoustic measure of jitter
J Speech Hear Res, 38 (1995), pp. 26-32
J.L. Fitch
Consistency of fundamental frequency and perturbation in repeated phonations of sustained vowels, reading, and connected speech
J Speech Hear Disord, 55 (1990), pp. 360-363
S. Nittrouer,R.S. McGowan,P.H. Milenkovic,D. Beehler
Acoustic measurements of men's and women's voices: a study of context effects and covariation
J Speech Hear Res, 33 (1990), pp. 761-775
R.F. Orlikoff,R.J. Baken
Consideration of the relationship between the fundamental frequency of phonation and vocal jitter
Folia Phoniatr, 4 (1990), pp. 31-40
M.P. Gelfer
Fundamental frequency, intensity, and vowel selection: effects on measures of phonatory stability
J Speech Hear Res, 38 (1995), pp. 1189-1198
M. Brockmann,M.J. Drinnan,C. Storck,P.N. Carding
Reliable jitter and shimmer measurements in voice clinics: the relevance of vowel, gender, vocal intensity, and fundamental frequency effects in a typical clinical task
S. Bielamowicz,J. Kreiman,B.R. Gerratt,M.S. Dauer,G.S. Berke
Comparison of voice analysis systems for perturbation measurement
J Speech Hear Res, 39 (1996), pp. 126-134
R.D. Kent,H.K. Vorperian,J.F. Kent,J.R. Duffy
Voice dysfunction in dysarthria: application of the Multi-Dimensional Voice Program
J Commun Disord, 36 (2003), pp. 281-306

Please cite this article as: Barcelos CB, Silveira PA, Guedes RL, Gonçalves AN, Slobodticov LD, Angelis EC. Multidimensional effects of voice therapy in patients affected by unilateral vocal fold paralysis due to cancer. Braz J Otorhinolaryngol. 2017.

Peer Review under the responsibility of Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial.

Corresponding author. (Renata Lígia Vieira Guedes
Copyright © 2017. Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial